Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Completed
Achillion, a wholly owned subsidiary of Alexion
Phase 2
2017-03-31
The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known
as danicopan and ALXN2040) in currently untreated participants with PNH.
Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Completed
Achillion Pharmaceuticals
Phase 2
2017-03-31
The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known
as danicopan and ALXN2040) in currently untreated participants with PNH.
Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Completed
Alexion Pharmaceuticals
Phase 2
2017-03-31
The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known
as danicopan and ALXN2040) in currently untreated participants with PNH.
A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants
Completed
Achillion, a wholly owned subsidiary of Alexion
Phase 1
2017-04-18
The purpose of this study was to determine the potential drug interaction between danicopan
(ACH-0144471) and midazolam, fexofenadine, and mycophenolate mofetil. This was a 3-part
study, with each part being an open-label, fixed-sequence, 2-treatment study in healthy adult
participants.
A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants
Completed
Achillion Pharmaceuticals
Phase 1
2017-04-18
The purpose of this study was to determine the potential drug interaction between danicopan
(ACH-0144471) and midazolam, fexofenadine, and mycophenolate mofetil. This was a 3-part
study, with each part being an open-label, fixed-sequence, 2-treatment study in healthy adult
participants.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
